Arrow Financial’s Elevance Health ELV Stock Holding History

Arrow Financial’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-39	Closed	-$20.3K	–	212
2024 Q3	$20.3K	Hold	39	–	–	﹤0.01%	264
2024 Q2	$21.1K	Hold	39	–	–	﹤0.01%	254
2024 Q1	$20.2K	Hold	39	–	–	﹤0.01%	253
2023 Q4	$18.4K	Sell	39 -6	-13%	-$2.77K	﹤0.01%	258
2023 Q3	$19.6K	Hold	45	–	–	﹤0.01%	263
2023 Q2	$20K	Hold	45	–	–	﹤0.01%	249
2023 Q1	$20.7K	Hold	45	–	–	﹤0.01%	250
2022 Q4	$23K	Hold	45	–	–	﹤0.01%	250
2022 Q3	$20K	Hold	45	–	–	﹤0.01%	256
2022 Q2	$22K	Sell	45 -5	-10%	-$2.47K	﹤0.01%	252
2022 Q1	$25K	Buy	+50	New	+$22.9K	﹤0.01%	256
2015 Q2	–	Sell	-19	Closed	-$3K	–	358
2015 Q1	$3K	Buy	+19	New	+$2.71K	﹤0.01%	350

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Arrow Financial's ELV Position: Q4 2024 in Review

Arrow Financial sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 39 shares — an estimated $20.3K sold.

Arrow Financial first reported a position in ELV in Q1 2015 and held it in 12 quarters. The position peaked at $25K in Q1 2022. 1,602 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

Arrow Financial reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
Arrow Financial sold 39 Elevance Health shares in Q4 2024, an estimated $20.3K.
Arrow Financial first reported a position in Elevance Health in Q1 2015 and held it in 12 quarters.
Arrow Financial's Elevance Health position peaked at $25K in Q1 2022.
1,602 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Arrow Financial's 13F filing for Q4 2024, filed 14 Feb 2025.